CureVac
GSK and CureVac to restructure collaboration into licensing agreement
July 3, 2024Sales and Marketing CureVac, GSK, Immunology, License Agreement, collaboration
GSK and CureVac have announced that they have restructured their existing collaboration into a license agreement, which is intended to …
CureVac and GSK begin phase 1 trial for mRNA flu vaccine candidates
May 9, 2023Medical Communications CureVac, GSK, Virology, clinical trial, mrna, vaccines
CureVac and GSK have announced that the first patient in the phase 1 section of their combined phase 1/2 trial …
Celonic to manufacture at least 100 million CureVac COVID-19 jabs
March 31, 2021Research and Development COVID-19, COVID-19 vaccine, CureVac, colonic, vaccine production
Celonic are to manufacture more than 100 million doses of CureVac’s COVID-19 vaccine, with 50 million shots expected to be …
Novartis signs agreement to manufacture CureVac’s COVID-19 vaccine
March 5, 2021Medical Communications COVID-19, CureVac, Novartis, vaccines
CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV. Preparations for the …
CureVac enters collaboration with UK government on coronavirus variant vaccines
February 8, 2021Sales and Marketing COVID-19, CureVac
CureVac has entered a collaboration with the UK government to develop and manufacture potential vaccine candidates against coronavirus variants, with …
GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine
February 3, 2021Research and Development COVID-19, CureVac, GlaxoSmithKline
GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …
CureVac’s COVID-19 vaccine generates immune responses at Phase 1
November 11, 2020Research and Development COVID-19, CureVac, pharma
German biopharma firm CureVac has unveiled interim analysis data from a Phase1 study of its messenger RNA (mRNA) COVID-19 vaccine, CVnCoV, …
Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine
July 6, 2020Manufacturing and Production, Sales and Marketing COVID-19, CureVac, Vaccine, tesla
Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …
European Commission offers €80m to CureVac to develop coronavirus vaccine
March 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing CureVac, EU, US, coronavirus
Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …
Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims
March 16, 2020Sales and Marketing CureVac, Trump, US, coronavirus, pharma
President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …
Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership
October 19, 2017Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine
Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …
